Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 1.42
WAT's Cash to Debt is ranked higher than
53% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.21 vs. WAT: 1.42 )
Ranked among companies with meaningful Cash to Debt only.
WAT' s 10-Year Cash to Debt Range
Min: 0  Med: 1.00 Max: 336.71
Current: 1.42
0
336.71
Equity to Asset 0.48
WAT's Equity to Asset is ranked lower than
67% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. WAT: 0.48 )
Ranked among companies with meaningful Equity to Asset only.
WAT' s 10-Year Equity to Asset Range
Min: -0.04  Med: 0.44 Max: 0.7
Current: 0.48
-0.04
0.7
Interest Coverage 15.15
WAT's Interest Coverage is ranked lower than
65% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.79 vs. WAT: 15.15 )
Ranked among companies with meaningful Interest Coverage only.
WAT' s 10-Year Interest Coverage Range
Min: 1.86  Med: 17.72 Max: 9999.99
Current: 15.15
1.86
9999.99
F-Score: 7
Z-Score: 6.24
M-Score: -2.63
WACC vs ROIC
3.31%
37.93%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 27.61
WAT's Operating margin (%) is ranked higher than
93% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.48 vs. WAT: 27.61 )
Ranked among companies with meaningful Operating margin (%) only.
WAT' s 10-Year Operating margin (%) Range
Min: 8.08  Med: 24.60 Max: 28.55
Current: 27.61
8.08
28.55
Net-margin (%) 22.96
WAT's Net-margin (%) is ranked higher than
94% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. WAT: 22.96 )
Ranked among companies with meaningful Net-margin (%) only.
WAT' s 10-Year Net-margin (%) Range
Min: -1.78  Med: 18.02 Max: 25.03
Current: 22.96
-1.78
25.03
ROE (%) 24.88
WAT's ROE (%) is ranked higher than
94% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.29 vs. WAT: 24.88 )
Ranked among companies with meaningful ROE (%) only.
WAT' s 10-Year ROE (%) Range
Min: -13.59  Med: 37.73 Max: 68.79
Current: 24.88
-13.59
68.79
ROA (%) 12.11
WAT's ROA (%) is ranked higher than
87% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.43 vs. WAT: 12.11 )
Ranked among companies with meaningful ROA (%) only.
WAT' s 10-Year ROA (%) Range
Min: -1.81  Med: 15.53 Max: 22.73
Current: 12.11
-1.81
22.73
ROC (Joel Greenblatt) (%) 77.15
WAT's ROC (Joel Greenblatt) (%) is ranked higher than
93% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. WAT: 77.15 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WAT' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 15.56  Med: 94.67 Max: 137.37
Current: 77.15
15.56
137.37
Revenue Growth (3Y)(%) 5.20
WAT's Revenue Growth (3Y)(%) is ranked higher than
52% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. WAT: 5.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WAT' s 10-Year Revenue Growth (3Y)(%) Range
Min: 5.2  Med: 10.20 Max: 19.5
Current: 5.2
5.2
19.5
EBITDA Growth (3Y)(%) 4.00
WAT's EBITDA Growth (3Y)(%) is ranked lower than
58% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. WAT: 4.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
WAT' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 2.4  Med: 11.80 Max: 69.7
Current: 4
2.4
69.7
EPS Growth (3Y)(%) 2.60
WAT's EPS Growth (3Y)(%) is ranked lower than
57% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. WAT: 2.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WAT' s 10-Year EPS Growth (3Y)(%) Range
Min: 2.6  Med: 15.75 Max: 79.2
Current: 2.6
2.6
79.2
» WAT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

WAT Guru Trades in Q3 2014

Ray Dalio 3,600 sh (New)
Joel Greenblatt 137,466 sh (New)
Jim Simons 289,500 sh (+1439.89%)
Paul Tudor Jones 5,568 sh (+26.55%)
Pioneer Investments 21,592 sh (unchged)
Chuck Royce 13,250 sh (unchged)
Ruane Cunniff 2,050,578 sh (-0.77%)
Jeremy Grantham 174,539 sh (-0.85%)
PRIMECAP Management 983,434 sh (-5.05%)
» More
Q4 2014

WAT Guru Trades in Q4 2014

Jim Simons 494,700 sh (+70.88%)
Chuck Royce 13,250 sh (unchged)
Ray Dalio Sold Out
Ruane Cunniff 2,049,064 sh (-0.07%)
PRIMECAP Management 975,734 sh (-0.78%)
Jeremy Grantham 164,415 sh (-5.80%)
Pioneer Investments 16,512 sh (-23.53%)
Paul Tudor Jones 3,600 sh (-35.34%)
Joel Greenblatt 56,395 sh (-58.98%)
» More
Q1 2015

WAT Guru Trades in Q1 2015

John Hussman 27,000 sh (New)
Chuck Royce 15,450 sh (+16.60%)
Ruane Cunniff 2,049,264 sh (+0.01%)
Paul Tudor Jones Sold Out
PRIMECAP Management 973,611 sh (-0.22%)
Jim Simons 415,100 sh (-16.09%)
Jeremy Grantham 137,415 sh (-16.42%)
Joel Greenblatt 46,450 sh (-17.63%)
Pioneer Investments 2,825 sh (-82.89%)
» More
Q2 2015

WAT Guru Trades in Q2 2015

Paul Tudor Jones 5,788 sh (New)
Ray Dalio 3,665 sh (New)
Joel Greenblatt 89,108 sh (+91.84%)
Ruane Cunniff 2,050,465 sh (+0.06%)
Chuck Royce 15,450 sh (unchged)
Pioneer Investments Sold Out
Jeremy Grantham 128,515 sh (-6.48%)
John Hussman 20,000 sh (-25.93%)
PRIMECAP Management 711,722 sh (-26.90%)
Jim Simons 114,685 sh (-72.37%)
» More
» Details

Insider Trades

Latest Guru Trades with WAT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.87
WAT's P/E(ttm) is ranked higher than
67% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.00 vs. WAT: 21.87 )
Ranked among companies with meaningful P/E(ttm) only.
WAT' s 10-Year P/E(ttm) Range
Min: 9.62  Med: 20.72 Max: 32.19
Current: 21.87
9.62
32.19
Forward P/E 18.80
WAT's Forward P/E is ranked higher than
63% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.74 vs. WAT: 18.80 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 22.50
WAT's PE(NRI) is ranked higher than
65% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.40 vs. WAT: 22.50 )
Ranked among companies with meaningful PE(NRI) only.
WAT' s 10-Year PE(NRI) Range
Min: 9.61  Med: 20.74 Max: 32.25
Current: 22.5
9.61
32.25
P/B 5.19
WAT's P/B is ranked lower than
77% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. WAT: 5.19 )
Ranked among companies with meaningful P/B only.
WAT' s 10-Year P/B Range
Min: 4.38  Med: 6.82 Max: 19.91
Current: 5.19
4.38
19.91
P/S 5.03
WAT's P/S is ranked lower than
71% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. WAT: 5.03 )
Ranked among companies with meaningful P/S only.
WAT' s 10-Year P/S Range
Min: 2.05  Med: 4.36 Max: 5.65
Current: 5.03
2.05
5.65
PFCF 22.72
WAT's PFCF is ranked higher than
69% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.56 vs. WAT: 22.72 )
Ranked among companies with meaningful PFCF only.
WAT' s 10-Year PFCF Range
Min: 9.67  Med: 20.94 Max: 32.21
Current: 22.72
9.67
32.21
POCF 18.32
WAT's POCF is ranked higher than
51% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.43 vs. WAT: 18.32 )
Ranked among companies with meaningful POCF only.
WAT' s 10-Year POCF Range
Min: 7.83  Med: 17.07 Max: 24.7
Current: 18.32
7.83
24.7
EV-to-EBIT 16.40
WAT's EV-to-EBIT is ranked higher than
63% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.58 vs. WAT: 16.40 )
Ranked among companies with meaningful EV-to-EBIT only.
WAT' s 10-Year EV-to-EBIT Range
Min: 8.4  Med: 16.50 Max: 25.2
Current: 16.4
8.4
25.2
PEG 2.59
WAT's PEG is ranked higher than
53% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.66 vs. WAT: 2.59 )
Ranked among companies with meaningful PEG only.
WAT' s 10-Year PEG Range
Min: 0.6  Med: 1.63 Max: 4.26
Current: 2.59
0.6
4.26
Shiller P/E 24.50
WAT's Shiller P/E is ranked higher than
59% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.14 vs. WAT: 24.50 )
Ranked among companies with meaningful Shiller P/E only.
WAT' s 10-Year Shiller P/E Range
Min: 13.57  Med: 25.39 Max: 44.59
Current: 24.5
13.57
44.59
Current Ratio 5.50
WAT's Current Ratio is ranked higher than
85% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. WAT: 5.50 )
Ranked among companies with meaningful Current Ratio only.
WAT' s 10-Year Current Ratio Range
Min: 1.19  Med: 1.85 Max: 5.5
Current: 5.5
1.19
5.5
Quick Ratio 5.00
WAT's Quick Ratio is ranked higher than
88% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. WAT: 5.00 )
Ranked among companies with meaningful Quick Ratio only.
WAT' s 10-Year Quick Ratio Range
Min: 0.74  Med: 1.38 Max: 5
Current: 5
0.74
5
Days Inventory 115.53
WAT's Days Inventory is ranked higher than
57% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.59 vs. WAT: 115.53 )
Ranked among companies with meaningful Days Inventory only.
WAT' s 10-Year Days Inventory Range
Min: 96.3  Med: 109.47 Max: 155.02
Current: 115.53
96.3
155.02
Days Sales Outstanding 73.03
WAT's Days Sales Outstanding is ranked lower than
67% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.01 vs. WAT: 73.03 )
Ranked among companies with meaningful Days Sales Outstanding only.
WAT' s 10-Year Days Sales Outstanding Range
Min: 67.61  Med: 79.83 Max: 89.8
Current: 73.03
67.61
89.8

Valuation & Return

vs
industry
vs
history
Price/Net Cash 89.25
WAT's Price/Net Cash is ranked lower than
93% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.72 vs. WAT: 89.25 )
Ranked among companies with meaningful Price/Net Cash only.
WAT' s 10-Year Price/Net Cash Range
Min: 94.4  Med: 177.42 Max: 401.52
Current: 89.25
94.4
401.52
Price/Net Current Asset Value 11.02
WAT's Price/Net Current Asset Value is ranked lower than
63% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.89 vs. WAT: 11.02 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
WAT' s 10-Year Price/Net Current Asset Value Range
Min: 9.08  Med: 19.26 Max: 310.33
Current: 11.02
9.08
310.33
Price/Tangible Book 7.40
WAT's Price/Tangible Book is ranked lower than
70% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.27 vs. WAT: 7.40 )
Ranked among companies with meaningful Price/Tangible Book only.
WAT' s 10-Year Price/Tangible Book Range
Min: 6.38  Med: 12.54 Max: 1313.3
Current: 7.4
6.38
1313.3
Price/Projected FCF 1.66
WAT's Price/Projected FCF is ranked higher than
53% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. WAT: 1.66 )
Ranked among companies with meaningful Price/Projected FCF only.
WAT' s 10-Year Price/Projected FCF Range
Min: 0.87  Med: 1.61 Max: 11.02
Current: 1.66
0.87
11.02
Price/DCF (Earnings Based) 1.25
WAT's Price/DCF (Earnings Based) is ranked higher than
68% of the 19 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.72 vs. WAT: 1.25 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.15
WAT's Price/Median PS Value is ranked lower than
53% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. WAT: 1.15 )
Ranked among companies with meaningful Price/Median PS Value only.
WAT' s 10-Year Price/Median PS Value Range
Min: 0.14  Med: 0.97 Max: 3.56
Current: 1.15
0.14
3.56
Price/Peter Lynch Fair Value 3.17
WAT's Price/Peter Lynch Fair Value is ranked lower than
79% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. WAT: 3.17 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
WAT' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.68  Med: 1.56 Max: 5.59
Current: 3.17
0.68
5.59
Price/Graham Number 2.66
WAT's Price/Graham Number is ranked lower than
56% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. WAT: 2.66 )
Ranked among companies with meaningful Price/Graham Number only.
WAT' s 10-Year Price/Graham Number Range
Min: 2.28  Med: 3.47 Max: 20.36
Current: 2.66
2.28
20.36
Earnings Yield (Greenblatt) (%) 6.07
WAT's Earnings Yield (Greenblatt) (%) is ranked higher than
77% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. WAT: 6.07 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
WAT' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 4  Med: 6.05 Max: 11.9
Current: 6.07
4
11.9
Forward Rate of Return (Yacktman) (%) 10.47
WAT's Forward Rate of Return (Yacktman) (%) is ranked lower than
55% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.13 vs. WAT: 10.47 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
WAT' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 8.9  Med: 15.70 Max: 27.6
Current: 10.47
8.9
27.6

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 2,033 2,158 2,325
EPS($) 5.82 6.46 7.25
EPS without NRI($) 5.82 6.46 7.25

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:WAZ.Germany,
Waters Corp incorporated as a Delaware corporation in 1991, is an analytical instrument manufacturer, mainly designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography, ultra performance liquid chromatography and mass spectrometry instrument systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Waters became a publicly-traded company with its initial public offering ("IPO") in November 1995. The Company's two operating segments, Waters Division and TA Division, have similar economic characteristics; product processes; products and services; types and classes of customers; methods of distribution and regulatory environments. The Waters Division's products and services consist of high performance liquid chromatography ("HPLC"), ultra performance liquid chromatography ("UPLC" and together with HPLC, referred to as "LC"), mass spectrometry ("MS") and chemistry consumable products and related services. TA products and services consist of thermal analysis, rheometry and calorimetry instrument systems and service sales. The Company's products are used by pharmaceutical, life science, biochemical, industrial, nutritional safety, environmental, academic and governmental customers. These customers use the Company's products to detect, identify, monitor and measure the chemical, physical and biological composition of materials and to predict the suitability of fine chemicals, pharmaceuticals, water, polymers and viscous liquids in various industrial, consumer goods and healthcare products. The Company's competitors include: Agilent Technologies, Inc., Shimadzu Corporation, Bruker Corporation, Danaher Corporation and Thermo Fisher Scientific Inc. In the markets served by the TA Division, the Company's principal competitors include: PerkinElmer, Inc., Mettler-Toledo International Inc., NETZSCH-Geraetebau GmbH, Thermo Fisher Scientific Inc., Malvern Instruments Ltd., Anton-Paar and General Electric Company.
» More Articles for WAT

Headlines

Articles On GuruFocus.com
candidate Aug 28 2015 
candidate Aug 28 2015 
candidate Aug 28 2015 
Study May 29 2015 
Weekly Insider Sells Highlight: WAT, KO, GILD, AZO, MAS Dec 14 2014 
Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY Dec 08 2014 
Our Investment Strategy and Portfolio Selection Nov 09 2014 
Guru-Held Stocks Trading At Historical Low P/B Oct 08 2014 
Guru Held Stocks Near Historical Low P/B Jul 22 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Jun 02 2014 

More From Other Websites
Coverage initiated on Waters by Cantor Fitzgerald Aug 27 2015
WATERS CORP /DE/ Financials Aug 15 2015
Waters Corp. Earnings Q2*, 2015 Aug 11 2015
10-Q for Waters Corp. Aug 10 2015
WATERS CORP /DE/ Files SEC form 10-Q, Quarterly Report Aug 07 2015
​Which Mass. life science firm is sitting on the most cash? It’s not who you think Aug 06 2015
Waters (WAT) Earnings Report: Q2 2015 Conference Call Transcript Jul 28 2015
Edited Transcript of WAT earnings conference call or presentation 28-Jul-15 12:30pm GMT Jul 28 2015
Waters Corp. Winning Streak Alive with Q2 Earnings Beat - Analyst Blog Jul 28 2015
Waters Corp Earnings Call scheduled for 8:30 am ET today Jul 28 2015
Waters Corp. (WAT) Surpasses Q2 Earnings and Revenues - Tale of the Tape Jul 28 2015
Waters tops Street 2Q forecasts Jul 28 2015
Waters tops Street 2Q forecasts Jul 28 2015
WATERS CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 28 2015
Q2 2015 Waters Corp Earnings Release - Before Market Open Jul 28 2015
Waters Reports Second Quarter 2015 Financial Results Jul 28 2015
Waters Corp. (WAT) Preview: Will it Beat Earnings Again? - Analyst Blog Jul 24 2015
Waters Corporation Q2 2015 Financial Results Webcast Invitation Jul 07 2015
WATERS CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Jun 25 2015
Waters Corporation Announces Christopher J. O'Connell as Chief Executive Officer Jun 25 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK